31:
975:
Wei, Changli; El Hindi, Shafic; Li, Jing; Fornoni, Alessia; Goes, Nelson; Sageshima, Junichiro; Maiguel, Dony; Karumanchi, S Ananth; Yap, Hui-Kim; Saleem, Moin; Zhang, Qingyin; Nikolic, Boris; Chaudhuri, Abanti; Daftarian, Pirouz; Salido, Eduardo; Torres, Armando; Salifu, Moro; Sarwal, Minnie M.;
774:
Hayek, Salim S.; Leaf, David E.; Samman Tahhan, Ayman; Raad, Mohamad; Sharma, Shreyak; Waikar, Sushrut S.; Sever, Sanja; Camacho, Alex; Wang, Xuexiang; Dande, Ranadheer R.; Ibrahim, Nasrien E.; Baron, Rebecca M.; Altintas, Mehmet M.; Wei, Changli; Sheikh-Hamad, David; Pan, Jenny S.-C.; Holliday,
364:
and he has been a member of
Medical Executive Committee (MEC) (2014–2016), Committee on Senior Faculty Appointments and Promotions (COSFAP) (2014, Chair 2015–2016), Committee on Student Evaluation and Promotion (COSEP) (2014–2016), and Conflict of Interest and Commitment Committee (COIIR) (since
348:
In 2010, he was elected as the Vice Chair for
Research by the Department of Medicine. In 2011, he took up the role of Endowed (Peggy and Harold Katz) Chair in Vascular Biology and Kidney Disease. In 2012, he was promoted to interim chairman of Medicine at the University of Miami Miller School of
473:
As a healthcare leader, Reiser engages others to work in a team-focused approach, which drives success and motivation. Forward thinking and disruptive in the idea, he leads with transparency and accountability, applying a data-driven approach to ensure successful navigation through the complex
721:
Hayek, Salim S.; Sever, Sanja; Ko, Yi-An; Trachtman, Howard; Awad, Mosaab; Wadhwani, Shikha; Altintas, Mehmet M.; Wei, Changli; Hotton, Anna L.; French, Audrey L.; Sperling, Laurence S.; Lerakis, Stamatios; Quyyumi, Arshed A.; Reiser, Jochen (2015).
227:(FSGS). These studies have broad clinical significance and lay the foundation for creation of novel diagnostics and pharmaco-therapeutics with potential benefit for a large patient population. His studies on suPAR molecule were featured in
690:
450:
Reiser has published more than 220 papers, which have received in excess of 21000 citations. He has been involved in editorial activities of various scientific journals including
596:
936:
1132:
1224:
976:
Schaefer, Franz; Morath, Christian; Schwenger, Vedat; Zeier, Martin; Gupta, Vineet; Roth, David; Rastaldi, Maria Pia; Burke, George; Ruiz, Phillip; Reiser, Jochen (2011).
961:
1209:
494:
443:
has done for cardiovascular disease", he says. His work has been responsible for new research fields and is significantly sparking new therapeutic approaches for
341:. He was also appointed as the Chief of Division of Nephrology and Hypertension and the Director of the Peggy and Harold Katz Family Drug Center Institute at the
455:
824:
487:
388:
biology and glomerular diseases. His laboratory has been developing therapies and assays to combat renal diseases and its many complications since 2004.
231:
in 2018. Reiser has been an advocate of science and innovation for two decades and was named as an inventor on multiple patents. He is co-founder of
252:
72:
1219:
1214:
1199:
604:
568:
937:"It's official: Jochen Reiser appointed by UT Regents as next president of The University of Texas Medical Branch | University of Texas System"
1189:
1194:
1093:
649:
636:
287:
279:
427:
is a global risk factor for kidney diseases and lower levels of it are better for any of them. He also compares the characteristics of
1107:
1054:
501:
400:
369:
224:
184:
148:
90:
451:
303:
201:
Prior to joining the
University of Texas Medical Branch, he served as the Ralph C Brown Professor and the Chairman of Medicine at
1204:
463:
894:
653:
1184:
550:
508:
357:
299:
202:
191:. As chief executive officer, he oversees the enterprise which includes multiple campuses, five health science colleges, the
1229:
1179:
643:
616:
192:
559:
He was awarded visiting professorship or honored as keynote speaker by various universities and institutions including
318:
in 2005. In 2007, he founded and directed the MGH Program in
Glomerular Disease, which runs the first of its kind at a
205:. Reiser's research has provided important mechanistic insights into the molecular pathogenesis of kidney diseases.
576:
330:
269:
Pathobiologie der
Podozyten: Molekulare Analyse der glomerulären Schlitzmembran und Fortsatzdynamik von Podozyten
232:
1174:
592:
588:
584:
560:
423:
may link the innate immune system functionally to the kidney – a novel, potentially fundamental concept. "
412:
326:
315:
295:
213:
86:
187:(UTMB) and CEO of the UTMB Health System, which includes the oldest medical school and nursing school in
629:
608:
564:
236:
163:
1169:
909:"University of Miami Miller School of Medicine – Katz Family Division of Nephrology and Hypertension"
459:
291:
691:"Jochen Reiser appointed by UT Regents as next president of The University of Texas Medical Branch"
663:
541:
416:
353:
342:
275:
217:
180:
368:
In May 2023, the
University of Texas System Board of Regents appointed Reiser as President of the
223:
suPAR is investigated as potential causative agent contributing to many kidney diseases including
1025:
319:
176:
360:
in
September 2012. Reiser’s academic career has centered on his role as Chairman of Medicine at
775:
Michael W.; Januzzi, James L.; Weisbord, Steven D.; Quyyumi, Arshed A.; Reiser, Jochen (2020).
1007:
806:
753:
572:
283:
228:
997:
989:
796:
788:
743:
735:
580:
512:
212:(soluble urokinase plasminogen activator receptor) as a global, circulating risk factor for
1111:
1058:
825:"What's your risk of kidney disease, heart attack, or diabetes? A single molecule can tell"
391:
His contributions range from identification of a common circulating blood protein —soluble
704:
612:
600:
546:
2016: Franz
Volhard Award (the highest research award of the German Society of Nephrology)
467:
361:
264:
195:
1149:
1038:
1042:
1002:
977:
801:
776:
748:
723:
444:
523:
The significance of his work has been recognized by numerous distinctions and awards:
239:
joint-venture biopharmaceutical portfolio company dedicated to develop first-in-class
1163:
356:, Reiser was appointed as The Ralph C Brown MD Professor and Chairman of Medicine by
1094:"Physician-Researcher Jochen Reiser, M.D., Ph.D., Recognized for Scholarly Activity"
482:
Reiser has been an active member of the following prestigious physician societies:
338:
260:
240:
866:
978:"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis"
852:
432:
1079:
256:
138:
30:
531:
408:
392:
373:
82:
52:
1011:
908:
810:
757:
1080:"The recipients of the 3ARP (Ajinomoto Amino Acid Research Program) grant"
792:
739:
314:
Reiser’s independent academic career started as an assistant professor at
669:
385:
923:"University of Miami Miller School of Medicine – Department of Medicine"
880:
659:
516:
365:
2013). He currently serves on the
Faculty Council for Rush University.
334:
853:"Medical Faculty Heidelberg – Institute for Anatomy and Cell Biology"
440:
993:
895:"Brigham and Women's Hospital – Division of Renal (Kidney) Medicine"
838:
114:
Provost’s Award for
Scholarly Activity (University of Miami, 2012);
535:
436:
428:
424:
420:
404:
396:
209:
188:
94:
922:
198:
and the Correctional Health Care Services for most of Texas.
108:
Young Investigator Award (German Society of Nephrology, 2005);
120:
Research Faculty Award (Rush University Medical Center, 2017)
527:
2005: Young Investigator Award, German Society of Nephrology
93:(FSGS), Soluble urokinase plasminogen activator receptor (
705:"Rush University – Internal Medicine – Faculty Directory"
117:
Franz Volhard Award (German Society of Nephrology, 2016);
278:
in Molecular and Cellular Biology and Kidney Disease at
111:
Scholar Award for Amino Acid Research (Ajinomoto, 2007);
724:"Soluble Urokinase Receptor and Chronic Kidney Disease"
1133:"Faculty Recognition – Rush University Medical Center"
881:"Massachusetts General Hospital – Nephrology Division"
597:
University of California San Francisco Medical Center
777:"Soluble Urokinase Receptor and Acute Kidney Injury"
183:
and a healthcare leader. He is the President of the
962:"Reiser Laboratory, Rush University Medical Center"
251:Reiser received his medical and Ph.D. degrees from
158:
144:
134:
101:
78:
68:
60:
37:
21:
474:financial and academic world of healthcare today.
352:After having served in various capacities at the
259:, Germany]], in 1998 and 1999, respectively. His
1026:"Early warning found for chronic kidney disease"
495:American Clinical and Climatological Association
271:at the Institute for Anatomy and Cell Biology,
540:2012: Provost’s Award for Scholarly Activity,
294:, he did fellowship training in Nephrology at
456:Journal of the American Society of Nephrology
331:University of Miami Miller School of Medicine
282:for a year. From 2000 to 2003, he trained in
8:
867:"Einstein/Montefiore Department of Medicine"
1108:"Träger des Franz-Volhard-Preises (1980–…)"
769:
767:
716:
714:
488:American Society for Clinical Investigation
466:, International Journal of Nephrology, and
29:
18:
1225:Expatriate academics in the United States
1055:"Träger des Carl-Ludwig-Preises (1997–…)"
1001:
800:
747:
439:targeting may do for kidney disease what
1210:German expatriates in the United States
682:
605:Icahn School of Medicine at Mount Sinai
569:University of California at Los Angeles
534:Scholar Award for Amino Acid Research,
666:in Internal Medicine (December, 2008)
253:Ruprecht-Karls-Universität Heidelberg
164:Office of the President - UTMB Health
73:Ruprecht-Karls-Universität Heidelberg
7:
325:After three years on the faculty of
650:United States Department of Justice
637:American Board of Internal Medicine
407:'s emerging role as earliest known
376:and CEO of the UTMB Health System.
288:Albert Einstein College of Medicine
280:Albert Einstein College of Medicine
619:(Invited National Speaker, 2022).
502:Association of American Physicians
401:focal segmental glomerulosclerosis
370:University of Texas Medical Branch
225:focal segmental glomerulosclerosis
185:University of Texas Medical Branch
149:University of Texas Medical Branch
91:Focal segmental glomerulosclerosis
14:
623:Board certification and licensure
555:2019: Hero of Medicine Halo Award
452:Journal of Clinical Investigation
464:American Journal of Therapeutics
395:plasminogen activator receptor (
781:New England Journal of Medicine
728:New England Journal of Medicine
654:Drug Enforcement Administration
16:German nephrologist (born 1971)
1220:21st-century German scientists
1215:20th-century German scientists
1200:Harvard Medical School faculty
551:Rush University Medical Center
549:2017: Research Faculty Award,
509:Academy of Sciences Leopoldina
358:Rush University Medical Center
300:Massachusetts General Hospital
235:-based Walden Biosciences, an
208:Reiser discovered the role of
203:Rush University Medical Center
1:
644:Commonwealth of Massachusetts
617:National Institutes of Health
411:for incident and progressive
384:Reiser's research focuses on
193:Galveston National Laboratory
1190:Heidelberg University alumni
571:(UCLA Kleeman Award, 2013),
304:Brigham and Women’s Hospital
1195:University of Miami faculty
734:(20). nejm.org: 1916–1925.
1246:
988:(8). nature.com: 952–960.
399:)— in the pathogenesis of
1110:. dgfn.eu. Archived from
1057:. dgfn.eu. Archived from
925:. medicine.med.miami.edu.
911:. medicine.med.miami.edu.
628:German Medical License –
577:University of Mississippi
154:
127:
28:
1041:publications indexed by
787:(5). nejm.org: 416–426.
233:Cambridge, Massachusetts
175:(born June 23, 1971, in
1205:Rush University faculty
897:. brighamandwomens.org.
642:Full Medical License –
575:First Hospital (2013),
380:Scientific contribution
85:, Glomerular diseases,
672:Medical License (2013)
639:(ABIM) (October, 2003)
593:Johns Hopkins Hospital
589:University of Michigan
585:Harvard Medical School
561:Weill Cornell Medicine
413:chronic kidney disease
327:Harvard Medical School
322:-affiliated hospital.
316:Harvard Medical School
296:Harvard Medical School
214:chronic kidney disease
87:Chronic kidney disease
1185:People from Pforzheim
793:10.1056/NEJMoa1911481
740:10.1056/NEJMoa1506362
630:Approbation (Germany)
609:University of Alabama
565:The Rogosin Institute
415:(CKD) as well as for
243:for kidney diseases.
237:ARCH Venture Partners
1230:Physician-scientists
1180:German nephrologists
855:. uni-heidelberg.de.
839:"Walden Biosciences"
656:(DEA) License (2005)
460:Kidney International
292:residency (medicine)
1028:. sciencedaily.com.
664:Board Certification
542:University of Miami
417:acute kidney injury
354:University of Miami
343:University of Miami
276:postdoctoral fellow
218:acute kidney injury
181:physician-scientist
883:. massgeneral.org.
869:. einstein.yu.edu.
333:as a professor of
320:Harvard University
177:Pforzheim, Germany
1150:"The Halo Awards"
1138:. rushu.rush.edu.
964:. rushu.rush.edu.
827:. sciencemag.org.
635:Diplomate of the
573:Peking University
567:Lecturer; 2013),
478:Awards and honors
284:Internal Medicine
170:
169:
129:Scientific career
1237:
1154:
1153:
1152:. halocures.com.
1146:
1140:
1139:
1137:
1129:
1123:
1122:
1120:
1119:
1104:
1098:
1097:
1096:. med.miami.edu.
1090:
1084:
1083:
1082:. ajinomoto.com.
1076:
1070:
1069:
1067:
1066:
1051:
1045:
1036:
1030:
1029:
1022:
1016:
1015:
1005:
972:
966:
965:
958:
952:
951:
949:
948:
941:www.utsystem.edu
933:
927:
926:
919:
913:
912:
905:
899:
898:
891:
885:
884:
877:
871:
870:
863:
857:
856:
849:
843:
842:
835:
829:
828:
821:
815:
814:
804:
771:
762:
761:
751:
718:
709:
708:
701:
695:
694:
687:
662:Medical License
581:Brown University
513:National Academy
329:, he joined the
166:
48:
46:
33:
19:
1245:
1244:
1240:
1239:
1238:
1236:
1235:
1234:
1160:
1159:
1158:
1157:
1148:
1147:
1143:
1135:
1131:
1130:
1126:
1117:
1115:
1106:
1105:
1101:
1092:
1091:
1087:
1078:
1077:
1073:
1064:
1062:
1053:
1052:
1048:
1037:
1033:
1024:
1023:
1019:
994:10.1038/nm.2411
982:Nature Medicine
974:
973:
969:
960:
959:
955:
946:
944:
935:
934:
930:
921:
920:
916:
907:
906:
902:
893:
892:
888:
879:
878:
874:
865:
864:
860:
851:
850:
846:
837:
836:
832:
823:
822:
818:
773:
772:
765:
720:
719:
712:
703:
702:
698:
689:
688:
684:
679:
625:
613:Duke University
601:Yale University
480:
382:
362:Rush University
312:
267:, was entitled
265:summa cum laude
249:
162:
123:
69:Alma mater
64:American/German
56:
50:
44:
42:
24:
17:
12:
11:
5:
1243:
1241:
1233:
1232:
1227:
1222:
1217:
1212:
1207:
1202:
1197:
1192:
1187:
1182:
1177:
1172:
1162:
1161:
1156:
1155:
1141:
1124:
1099:
1085:
1071:
1046:
1043:Google Scholar
1031:
1017:
967:
953:
928:
914:
900:
886:
872:
858:
844:
830:
816:
763:
710:
696:
681:
680:
678:
675:
674:
673:
667:
657:
647:
640:
633:
624:
621:
557:
556:
553:
547:
544:
538:
528:
521:
520:
505:
498:
491:
479:
476:
445:renal diseases
381:
378:
311:
308:
248:
245:
216:(CKD) and for
168:
167:
160:
156:
155:
152:
151:
146:
142:
141:
136:
132:
131:
125:
124:
122:
121:
118:
115:
112:
109:
105:
103:
99:
98:
80:
79:Known for
76:
75:
70:
66:
65:
62:
58:
57:
51:
39:
35:
34:
26:
25:
22:
15:
13:
10:
9:
6:
4:
3:
2:
1242:
1231:
1228:
1226:
1223:
1221:
1218:
1216:
1213:
1211:
1208:
1206:
1203:
1201:
1198:
1196:
1193:
1191:
1188:
1186:
1183:
1181:
1178:
1176:
1175:Living people
1173:
1171:
1168:
1167:
1165:
1151:
1145:
1142:
1134:
1128:
1125:
1114:on 2013-01-14
1113:
1109:
1103:
1100:
1095:
1089:
1086:
1081:
1075:
1072:
1061:on 2013-01-14
1060:
1056:
1050:
1047:
1044:
1040:
1039:Jochen Reiser
1035:
1032:
1027:
1021:
1018:
1013:
1009:
1004:
999:
995:
991:
987:
983:
979:
971:
968:
963:
957:
954:
942:
938:
932:
929:
924:
918:
915:
910:
904:
901:
896:
890:
887:
882:
876:
873:
868:
862:
859:
854:
848:
845:
840:
834:
831:
826:
820:
817:
812:
808:
803:
798:
794:
790:
786:
782:
778:
770:
768:
764:
759:
755:
750:
745:
741:
737:
733:
729:
725:
717:
715:
711:
706:
700:
697:
692:
686:
683:
676:
671:
668:
665:
661:
658:
655:
651:
648:
645:
641:
638:
634:
631:
627:
626:
622:
620:
618:
614:
610:
606:
602:
598:
594:
590:
586:
582:
578:
574:
570:
566:
562:
554:
552:
548:
545:
543:
539:
537:
533:
529:
526:
525:
524:
518:
514:
510:
506:
503:
499:
496:
492:
489:
485:
484:
483:
477:
475:
471:
469:
465:
461:
457:
453:
448:
446:
442:
438:
434:
430:
426:
422:
418:
414:
410:
406:
402:
398:
394:
389:
387:
379:
377:
375:
371:
366:
363:
359:
355:
350:
346:
344:
340:
336:
332:
328:
323:
321:
317:
309:
307:
305:
301:
297:
293:
289:
285:
281:
277:
274:He worked as
272:
270:
266:
262:
258:
254:
246:
244:
242:
238:
234:
230:
226:
221:
219:
215:
211:
206:
204:
199:
197:
194:
190:
186:
182:
178:
174:
173:Jochen Reiser
165:
161:
157:
153:
150:
147:
143:
140:
137:
133:
130:
126:
119:
116:
113:
110:
107:
106:
104:
100:
96:
92:
88:
84:
81:
77:
74:
71:
67:
63:
59:
54:
49:(age 53)
41:June 23, 1971
40:
36:
32:
27:
23:Jochen Reiser
20:
1144:
1127:
1116:. Retrieved
1112:the original
1102:
1088:
1074:
1063:. Retrieved
1059:the original
1049:
1034:
1020:
985:
981:
970:
956:
945:. Retrieved
943:. 2023-05-24
940:
931:
917:
903:
889:
875:
861:
847:
833:
819:
784:
780:
731:
727:
699:
685:
632:(July, 2000)
558:
522:
481:
472:
449:
390:
383:
367:
351:
347:
339:cell biology
324:
313:
298:-affiliated
290:. After his
273:
268:
261:dissertation
250:
241:therapeutics
222:
207:
200:
172:
171:
145:Institutions
128:
1170:1971 births
707:. rush.edu.
693:. utmb.edu.
615:(2021) and
433:cholesterol
431:to that of
61:Nationality
1164:Categories
1118:2017-08-02
1065:2017-08-02
947:2023-05-26
677:References
468:F1000Prime
403:(FSGS) to
349:Medicine.
302:(MGH) and
257:Heidelberg
139:Nephrology
45:1971-06-23
532:Ajinomoto
409:biomarker
393:urokinase
374:Galveston
247:Education
83:Podocytes
55:, Germany
53:Pforzheim
1012:21804539
811:31995687
758:26539835
670:Illinois
611:(2020),
607:(2019),
603:(2018),
599:(2017),
595:(2017),
591:(2016),
587:(2015),
583:(2015),
579:(2014),
458:(JASN),
386:podocyte
220:(AKI).
1003:4089394
802:7065830
749:4701036
660:Florida
517:Germany
441:statins
419:(AKI).
335:anatomy
306:(BWH).
229:Science
196:(BSL-4)
179:) is a
159:Website
89:(CKD),
43: (
1010:
1000:
809:
799:
756:
746:
652:(DOJ)
646:(2005)
530:2007:
507:2017:
500:2015:
497:(ACCA)
493:2012:
490:(ASCI)
486:2009:
310:Career
135:Fields
102:Awards
1136:(PDF)
536:Japan
511:(The
504:(AAP)
437:suPAR
429:suPAR
425:suPAR
421:suPAR
405:suPAR
397:suPAR
210:suPAR
189:Texas
95:suPAR
1008:PMID
807:PMID
754:PMID
337:and
38:Born
998:PMC
990:doi
797:PMC
789:doi
785:382
744:PMC
736:doi
732:373
515:of
372:in
345:.
286:at
255:in
1166::
1006:.
996:.
986:17
984:.
980:.
939:.
805:.
795:.
783:.
779:.
766:^
752:.
742:.
730:.
726:.
713:^
470:.
462:,
454:,
447:.
435:.
263:,
97:).
1121:.
1068:.
1014:.
992::
950:.
841:.
813:.
791::
760:.
738::
563:(
519:)
47:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
